Sealong Biotech: 1,041.59% jump in Q3 net profit & planned application for listing on BSE
Summary: Sealong Biotech's operating revenue and net profit attributable to equity holders for Q3 2022 both delivered year-on-year increases. Additionally, Sealong Biotech announced on 9 Nov. that the company was planning to apply for listing on BSE....
Amino Acids China E-News 202211